biomarker-trends-header.png

Qiagen receives FDA approval for EGFR mutation test

Qiagen Press Release.

Medicare Punts on Establishing Dx Reimbursement

by John Audette | Aug 28, 2013 | Marketing, News, Reimbursement

Medicare Has Stopped Paying Bills For Medical Diagnostic Tests. Patients Will Feel The Effects - Forbes.

EGFR Mutation Testing Rates in Canada Increased with Financial Support

CMAJ: Uneven accessibility to biomarker test for lung cancer.

   

December

Webinar: 

Pharmacovigilance and Safety Biomarkers

RECORDING
New Call-to-action
FREE REPORT

Subscribe for Updates

Download our Free IVD Trends Report